Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07689773 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT): Open Label

Study acronym: SCENT-OL
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Jul 8, 2026 to Jul 10, 2026 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Jul 8, 2026 to Jul 10, 2026
    • Site details revised
  2. Study description expanded, about 9 wordsv2 See this version in full on ClinicalTrials.gov ↗
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Smell dysfunction significantly impacts quality of life and safety, with limited effective treatments. This open-label study evaluates the preliminary efficacy of combining non-invasive trigeminal nerve stimulation (TNS) with standard smell training (ST) to improve olfactory function. Participants will complete 8 weeks of at-home treatment and attend three in-person visits for assessment. Improvements in smell, mood, sleep, and quality of life will be measured.
Trial Details
NCT Number NCT07689773
Lead Sponsor Medical University of South Carolina
Conditions Olfactory Impairment
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov